JP2006527264A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006527264A5 JP2006527264A5 JP2006516839A JP2006516839A JP2006527264A5 JP 2006527264 A5 JP2006527264 A5 JP 2006527264A5 JP 2006516839 A JP2006516839 A JP 2006516839A JP 2006516839 A JP2006516839 A JP 2006516839A JP 2006527264 A5 JP2006527264 A5 JP 2006527264A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- hydrogen atom
- formula
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CN(C)*[n]1ncc-2c1N(C)C(N)[n]1nc(*)nc-21 Chemical compound CN(C)*[n]1ncc-2c1N(C)C(N)[n]1nc(*)nc-21 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50904603P | 2003-06-10 | 2003-06-10 | |
| US60/509,046 | 2003-06-10 | ||
| US53279303P | 2003-12-24 | 2003-12-24 | |
| US60/532,793 | 2003-12-24 | ||
| PCT/JP2004/008486 WO2004108137A1 (en) | 2003-06-10 | 2004-06-10 | A method of treating an anxiety disorder |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006527264A JP2006527264A (ja) | 2006-11-30 |
| JP2006527264A5 true JP2006527264A5 (https=) | 2007-06-07 |
| JP4778894B2 JP4778894B2 (ja) | 2011-09-21 |
Family
ID=33514319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006516839A Expired - Fee Related JP4778894B2 (ja) | 2003-06-10 | 2004-06-10 | 不安障害の治療方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8202869B2 (https=) |
| EP (1) | EP1631294B1 (https=) |
| JP (1) | JP4778894B2 (https=) |
| KR (1) | KR20060037252A (https=) |
| CN (1) | CN1787821A (https=) |
| AT (1) | ATE481101T1 (https=) |
| AU (1) | AU2004244906A1 (https=) |
| BR (1) | BRPI0411120A (https=) |
| CA (1) | CA2528710C (https=) |
| CO (1) | CO5640121A2 (https=) |
| DE (1) | DE602004029160D1 (https=) |
| EA (1) | EA200501924A1 (https=) |
| MX (1) | MXPA05013148A (https=) |
| NO (1) | NO20055907L (https=) |
| WO (1) | WO2004108137A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101098209B1 (ko) * | 2002-01-28 | 2011-12-23 | 교와 핫꼬 기린 가부시키가이샤 | 운동성 질환에 걸린 환자의 치료 방법 |
| US10042980B2 (en) | 2005-11-17 | 2018-08-07 | Gearbox Llc | Providing assistance related to health |
| US20070136092A1 (en) * | 2005-11-30 | 2007-06-14 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging |
| US10296720B2 (en) | 2005-11-30 | 2019-05-21 | Gearbox Llc | Computational systems and methods related to nutraceuticals |
| US20070124176A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
| EP2089389A2 (en) | 2006-11-01 | 2009-08-19 | Bristol-Myers Squibb Company | Heterocyclic compounds as modulators of glucocorticoid receptor, ap-1, and/or nf-kappa-b activity |
| AU2008279169A1 (en) * | 2007-07-23 | 2009-01-29 | Biotie Therapies, Inc | 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide for the treatment of post-traumatic stress disorder |
| UA113383C2 (xx) * | 2009-09-02 | 2017-01-25 | Терапевтичний агент для лікування тривожних розладів | |
| UA110097C2 (uk) | 2009-09-02 | 2015-11-25 | Терапевтичний агент для лікування розладів настрою | |
| US8609162B2 (en) | 2012-10-04 | 2013-12-17 | Invivo Beverages Llc | Integrated neuromodulation system for mood enhancement of a living human subject |
| CN105770563A (zh) * | 2016-04-22 | 2016-07-20 | 孙建 | 一种治疗焦虑症的中药制剂及其制备方法 |
| TWI877770B (zh) | 2018-02-27 | 2025-03-21 | 美商英塞特公司 | 作為a2a / a2b抑制劑之咪唑并嘧啶及三唑并嘧啶 |
| EP3810610A1 (en) | 2018-05-18 | 2021-04-28 | Incyte Corporation | Fused pyrimidine derivatives as a2a / a2b inhibitors |
| WO2020010197A1 (en) | 2018-07-05 | 2020-01-09 | Incyte Corporation | Fused pyrazine derivatives as a2a / a2b inhibitors |
| TWI829857B (zh) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶 |
| WO2022167778A1 (en) | 2021-02-02 | 2022-08-11 | Haiku Therapeutics Ltd | Ebselen as adenosine receptor modulator |
| KR102594242B1 (ko) | 2023-01-10 | 2023-10-27 | 주식회사 웨이센 | 디지털 표현형 특징을 이용한 사회 불안장애 분석방법 및 장치 |
| KR102567684B1 (ko) | 2023-01-10 | 2023-08-18 | 주식회사 웨이센 | 디지털 표현형 특징을 이용한 사회 불안장애 분석방법 및 장치 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2051772T3 (es) * | 1986-09-30 | 1994-07-01 | Ciba Geigy Ag | 2-sustituido-e-fusionado-(1,2,4)-triazol(1,5-c)pirimidinas, composiciones farmaceuticas y sus usos. |
| US5047534A (en) * | 1990-03-26 | 1991-09-10 | Merrell Dow Pharmaceuticals Inc. | Selective adenosine receptor agents |
| US5484920A (en) | 1992-04-08 | 1996-01-16 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic agent for Parkinson's disease |
| ES2176204T3 (es) * | 1992-07-08 | 2002-12-01 | Kyowa Hakko Kogyo Kk | Antidepresivos que contienen un derivado de xantina. |
| DE69834500T2 (de) | 1997-09-05 | 2007-05-03 | Kyowa Hakko Kogyo Co., Ltd. | Xanthinderivative zur behandlung von hirnischämie |
| WO2000017201A1 (en) * | 1998-09-22 | 2000-03-30 | Kyowa Hakko Kogyo Co., Ltd. | [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES |
| AU4431000A (en) * | 1999-05-12 | 2000-12-05 | Fujisawa Pharmaceutical Co., Ltd. | Novel use |
| DE60110219T2 (de) * | 2000-05-26 | 2006-03-09 | Schering Corp. | Adenosin a2a rezeptor antagonisten |
| CA2459304A1 (en) * | 2001-09-13 | 2003-03-20 | Schering Corporation | Combination of an adenosine a2a receptor antagonist and an antidepressant or anxiolytic |
| KR100687954B1 (ko) * | 2001-10-15 | 2007-02-27 | 쉐링 코포레이션 | 아데노신 Ａ2ａ 수용체 길항제로서의이미다조（4,3-ｅ）-1,2,4-트리아졸로（1,5-ｃ） 피리미딘 |
| AU2002340405A1 (en) * | 2001-11-20 | 2003-06-10 | Bristol-Myers Squibb Pharma Company | 3,7-dihydro-purine-2,6-dione derivatives as crf receptor ligands |
| US20060128694A1 (en) * | 2002-12-19 | 2006-06-15 | Michael Grzelak | Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
-
2004
- 2004-06-10 KR KR1020057021878A patent/KR20060037252A/ko not_active Withdrawn
- 2004-06-10 DE DE602004029160T patent/DE602004029160D1/de not_active Expired - Lifetime
- 2004-06-10 CA CA2528710A patent/CA2528710C/en not_active Expired - Fee Related
- 2004-06-10 JP JP2006516839A patent/JP4778894B2/ja not_active Expired - Fee Related
- 2004-06-10 MX MXPA05013148A patent/MXPA05013148A/es unknown
- 2004-06-10 WO PCT/JP2004/008486 patent/WO2004108137A1/en not_active Ceased
- 2004-06-10 EA EA200501924A patent/EA200501924A1/ru unknown
- 2004-06-10 BR BRPI0411120-6A patent/BRPI0411120A/pt not_active IP Right Cessation
- 2004-06-10 EP EP04746014A patent/EP1631294B1/en not_active Expired - Lifetime
- 2004-06-10 AT AT04746014T patent/ATE481101T1/de not_active IP Right Cessation
- 2004-06-10 US US10/553,250 patent/US8202869B2/en not_active Expired - Fee Related
- 2004-06-10 AU AU2004244906A patent/AU2004244906A1/en not_active Abandoned
- 2004-06-10 CN CNA2004800128457A patent/CN1787821A/zh active Pending
-
2005
- 2005-12-13 NO NO20055907A patent/NO20055907L/no not_active Application Discontinuation
-
2006
- 2006-01-10 CO CO06001545A patent/CO5640121A2/es not_active Application Discontinuation
-
2012
- 2012-04-16 US US13/447,798 patent/US8592420B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006527264A5 (https=) | ||
| JPH08259567A (ja) | ピラゾロピリミジン類およびピロロピリミジン類によるニューロン疾患およびその他疾患の治療方法 | |
| JP6360025B2 (ja) | 有機化合物 | |
| JP6038250B2 (ja) | 有機化合物 | |
| JP5656874B2 (ja) | Ｐｄｅ９阻害剤として使用されるアミノヘテロ環化合物 | |
| JP2002533464A (ja) | プテリジン誘導体の免疫抑制作用 | |
| RU2007126570A (ru) | Аминоимидазолоны, применяемые для ингибирования бета-секретазы | |
| ITMI951671A1 (it) | Analoghi eterociclici di 1,2,4-triazolo[1,5-c]pirimidine ad attivita' antagonista per il recettore a2a dell'adenosina | |
| AU2008276455A1 (en) | Combinations for the treatment of B-cell proliferative disorders | |
| NO20055510L (no) | 2-alkynyl- og 2-alkenylpyrazolo [4,3-E]-1,2,4-triazolo-[1,5-C]-pyrimidin-adenosin A2A-reseptorantagonister | |
| AU2008276451A1 (en) | Treatments of B-cell proliferative disorders | |
| JP2009533343A5 (https=) | ||
| Janetka et al. | Inhibitors of checkpoint kinases: from discovery to the clinic | |
| JPH083041A (ja) | ストレス関連障害治療剤 | |
| EA200800992A1 (ru) | 2-амино-7,8-дигидро-6н-пиридо[4,3-d]пиримидин-5-оны, способ их получения, способ терапии с их помощью, компонент композиции и композиция на их основе, 2,4-диоксопиперидиновые соединения для их получения | |
| JP4778894B2 (ja) | 不安障害の治療方法 | |
| Albaugh et al. | Synthesis and Biological Evaluation of 7, 8, 9, 10-Tetrahydroimidazo [1, 2-c] pyrido [3, 4-e] pyrimdin-5 (6H)-ones as Functionally Selective Ligands of the Benzodiazepine Receptor Site on the GABAA Receptor | |
| JP2005503433A5 (https=) | ||
| CA2490254A1 (en) | Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them | |
| Vu et al. | Studies on adenosine A2A receptor antagonists: comparison of three core heterocycles | |
| WO2006097263A3 (de) | Kompatible solute enthaltende mittel zur oralen verwendung | |
| JP2003519080A5 (https=) | ||
| KR100820006B1 (ko) | 헤테로사이클릭 ｇａｂａ-ａ 아형 선택적 수용체 조절제 | |
| JP2025538452A (ja) | ９型ホスホジエステラーゼの阻害による特定の神経精神障害の治療または予防におけるセロトニン作動性幻覚薬の効力の増強 | |
| Taliani et al. | A3 receptor ligands: past, present and future trends |